APA (7th ed.) Citation

Nozomi Kawakami, Katsuhiro Miyoshi, Shuhei Horio, & Hiroyuki Fukui. (2004). β2-Adrenergic Receptor-Mediated Histamine H1 Receptor Down-Regulation: Another Possible Advantage of β2 Agonists in Asthmatic Therapy. Elsevier.

Chicago Style (17th ed.) Citation

Nozomi Kawakami, Katsuhiro Miyoshi, Shuhei Horio, and Hiroyuki Fukui. β2-Adrenergic Receptor-Mediated Histamine H1 Receptor Down-Regulation: Another Possible Advantage of β2 Agonists in Asthmatic Therapy. Elsevier, 2004.

MLA (9th ed.) Citation

Nozomi Kawakami, et al. β2-Adrenergic Receptor-Mediated Histamine H1 Receptor Down-Regulation: Another Possible Advantage of β2 Agonists in Asthmatic Therapy. Elsevier, 2004.